SEC Form 4 · accession 0001382963-15-000135
JUNIPER PHARMACEUTICALS INC · JNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank Condella Jr.
Officer — President & CEO
Period of report
Nov 18, 2015
Accepted (ET)
Nov 19, 2015 · 5:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| common stock, par value $0.01F1 | Nov 18, 2015 | P | 5,000 | $11.6804 | A | 79,720 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $11.67 to $11.69. The price reported reflects the weighted-average purchase price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range described above.